8JT8: 5-HT2AR

Crystal structure of 5-HT2AR in complex with (R)-IHCH-7179. Determined by X-ray diffraction at 2.7 Å resolution. Released 28 Feb 2024.

Method
X-ray diffraction
Resolution
2.7 Å
Organisms
Homo sapiens, Escherichia coli
Chains
1
Atoms
2,930
Mol. weight
46.08 kDa
Ligands
CLR, OLC, EZX, MG
Released
28 Feb 2024

Explore 8JT8 in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8JT8 contains 18 α-helices and 2 β-strands across 1 chain. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 18 helices, 2 β-strands

ElementResiduesLengthSheet
α-helix76-10126
α-helix103-1053
α-helix108-12215
α-helix123-1275
α-helix128-1369
α-helix145-1473
α-helix148-17528
α-helix189-20618
α-helix209-2146
α-helix218-2214
β-strand222-22321
β-strand226-22721
α-helix232-2398
α-helix240-2445
α-helix245-101738
α-helix1023-103917
α-helix1068-108013
α-helix1084-34859
α-helix355-38329
α-helix385-39511

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
5-hydroxytryptamine receptor 2A,Soluble cytochrome b562Aprotein376Homo sapiens, Escherichia coliP0ABE7 (AlphaFold model), P28223 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>8JT8_1 5-hydroxytryptamine receptor 2A,Soluble cytochrome b562 (chains A)
GGTHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFL
VMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTAKIWHLCAISLDRYVAIQNPIHHSRF
NSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIP
LTIMVITYFLTIKSLQKEAADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAG
SGSGDILVGQIDDALKLANEGKVKEAQAAAEQLKTTINAYIQKYGQSISNEQKACKVLGI
VFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLNSAVNPLVYTLFNKTY
RSAFSRYIQCQYKENK

Ligands and cofactors

IDNameFormulaCopies
CLRCholesterolC27 H46 O2
OLC(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoateC21 H40 O47
EZX1-(4-fluorophenyl)-4-[(7R)-2,5,11-triazatetracyclo[7.6.1.0^2,7.0^12,16]hexadeca…C23 H24 F N3 O1
MGMagnesium ionMg1

Water and common crystallization additives (PEG, 1PE) are not listed.

Primary citation

Flexible scaffold-based cheminformatics approach for polypharmacological drug design. Chen, Z., Yu, J., Wang, H. et al. Cell (2024) 187:2194-2208.e22. DOI 10.1016/j.cell.2024.02.034 · PubMed

Other PDB entries of the same protein (UniProt P0ABE7 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8JT8 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.